Newly approved myeloma treatment found highly effective in first real-world patient population
In a first test of more typical patients with multiple myeloma, a newly FDA-approved drug proved nearly as effective as in clinical trial
Stanford study offers hope to CAR T-cell therapy relapsed B cell lymphoma patients
In a small study, half of the patients whose lymphoma failed to respond to all previous treatments including CAR T-cell therapy, responded
FDA approves first T cell therapy for melanoma
CANCER DIGEST – Feb. 16, 2024 – The FDA today has approved a new T-cell therapy for the treatment of melanoma. The therapy called...
